Furthermore, we confirmed that HAR1A and HAR1B expression is comparable intra-tumour cell lines derived from both the GBM core and clinically relevant invasive margin, the latter region reflective of residual disease post-surgery. This evidence concerns the gene HAR1B and neoplasm.